Nippon Life's Superior Rating Affirmed Amidst Global Expansion Push

HONG KONG – January 30, 2026 – Global credit rating agency AM Best has affirmed its top-tier credit ratings for Nippon Life Insurance Company (Nissay), Japan's largest life insurer by revenue, signaling strong confidence in the company's financial stability as it pursues an aggressive international expansion strategy. The agency reaffirmed Nissay’s Financial Strength Rating (FSR) of A+ (Superior) and its Long-Term Issuer Credit Rating (Long-Term ICR) of “aa-” (Superior), maintaining a stable outlook for all ratings.

Concurrently, the ratings for Nissay’s U.S. subsidiary, Nippon Life Insurance Company of America (NLB), were affirmed at A- (Excellent) for its FSR and “a-” (Excellent) for its Long-Term ICR, also with a stable outlook. The affirmation comes at a pivotal moment for the Japanese insurance giant, which is leveraging its formidable financial strength to diversify its earnings and solidify its presence on the world stage through significant overseas acquisitions.

A Pillar of Financial Strength

AM Best's assessment underscores Nissay’s exceptionally robust financial health, citing its balance sheet strength as the “strongest.” This assessment is anchored by the company's risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR), which remains at the highest level. The insurer's substantial capital base, recorded at JPY 8.7 trillion (approximately USD 58 billion) as of March 31, 2025, provides a massive cushion against market shocks.

While this figure represents a decrease from an exceptionally high JPY 10.5 trillion the previous year—a dip attributed to declining unrealized gains on securities amidst adverse financial market conditions—the company has demonstrated remarkable resilience. Its capital base subsequently recovered to JPY 9.9 trillion by September 2025. This stability is further supported by a strong operating performance, which generated a core operating profit of JPY 1 trillion in fiscal-year 2025, driven by an expanding investment yield margin and contributions from its growing portfolio of overseas businesses.

The ratings agency highlighted Nissay’s prudent asset-liability management and sophisticated internal capital modeling as key strengths that help mitigate risks in an increasingly volatile interest rate environment. Despite moderate exposure to equity and interest rate risks from its large securities portfolio, its significant capital reserves are deemed more than sufficient to absorb potential stress.

Fueling an Ambitious Global Strategy

The affirmation of its superior creditworthiness provides a critical tailwind for Nissay's strategic pivot towards global markets. Facing a mature and highly penetrated domestic market characterized by an aging population, the insurer has embarked on a bold expansion to secure new avenues for growth and diversify its revenue streams.

This strategy was recently underscored by two major transactions. The first was the acquisition of a minority stake in U.S.-based Corebridge Financial. This was followed by a landmark deal to acquire 100% of Resolution Life Group Holdings Ltd., a specialist in managing in-force insurance portfolios, for approximately USD 8.2 billion. This acquisition, completed in October 2025, marks a significant step-change in Nissay's international profile.

AM Best noted that it expects the large-scale Resolution Life transaction to have a “limited impact” on Nissay’s fundamental balance sheet strength, though some erosion of its risk-adjusted capitalization is anticipated. The move is strategically designed to enhance earnings diversification and leverage Resolution Life’s expertise in asset and liability management. As part of the deal, Resolution Life's Australian operations will be merged with Nissay's existing Australian business, MLC Life Insurance, to create a new primary insurer named Acenda.

These moves align with the company's long-term vision to become a global corporate group offering a wide array of services beyond traditional life insurance, including asset management and healthcare, to provide what it terms “multidimensional peace of mind.”

A Tale of Two Markets: Domestic Dominance vs. U.S. Hurdles

While the parent company executes its global ambitions from a position of strength, the latest ratings also illuminate the contrasting operating environments for Nissay and its U.S. subsidiary. In Japan, Nissay remains a dominant force, commanding an impressive 19% of the premium income market share and leveraging a vast network of sales representatives and diversified distribution channels.

In contrast, its U.S. subsidiary, Nippon Life Insurance Company of America (NLB), navigates a more challenging and concentrated landscape. Although NLB also boasts a 'strongest' assessment for its risk-adjusted capitalization and a high-quality investment portfolio, its business profile is considered “limited.”

The press release from AM Best points to NLB’s concentration in the highly competitive group major medical market within specific U.S. states. This segment has experienced volatility, and the company has faced headwinds from “minimum loss ratio requirements,” a feature of U.S. health insurance regulation that mandates a certain percentage of premiums be spent on medical care, which has required the company to issue rebates.

Despite these hurdles, NLB maintains an established niche, particularly within Asian markets in the United States, buoyed by strong customer service and high retention rates. The subsidiary plans to expand into new U.S. markets to create new revenue opportunities, a move that aligns with its parent company’s overarching interest in the world's largest insurance market.